Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Read our detailed guide on alcohol and GLP-1 medications
Stopping abruptly can trigger withdrawal effects and rapid weight regain
The classification helps answer the question: "What am I actually taking, and how does it compare to what I read about online?" [Diagram suggestion: Four-quadrant matrix with axes labeled "Receptor target" (pure GLP-1 vs multi-agonist) and "Approval status" (FDA-approved vs compounded), with all medications plotted in their respective quadrants] The pattern we see in FormBlends refill data: patients often start on compounded semaglutide (Tier 4), then switch to brand-name Wegovy (Tier 1) when insurance coverage becomes available, then switch to tirzepatide (Tier 3) if weight loss plateaus
However, the effects of larger doses are not known
Sustainable long-term weight loss
US$ 22.00
US$ 28.73
US$ 20.07
US$ 24.33
US$ 22.54
US$ 26.52
US$ 25.92
US$ 29.59
US$ 28.99
